We recently published an article titled Jim Cramer on Super Micro Computer and Other Stocks. In this article, we are going to ...

Tesla’s sales in China increased by 19.2% in September, totaling over 72,000 electric vehicles sold, its best performance of ...

Bar Rua on the corner of Clarendon Street and Chatham Row/Chatham Street has been put on the market as Galway Bay Brewery ...

The patient reported no known drug allergies ... hydrochloride 50 mg orally four times daily and ranitidine hydrochloride 150 mg orally twice daily for 10 days, in addition to the prednisone ...

GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.

GSK did not admit wrongdoing as part of the deal, saying in a statement that there was "no consistent or reliable evidence" that ranitidine, the drug's active ingredient, increased the risk of cancer.

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on ...

GSK has agreed to pay up to $2.2 billion to resolve approximately 80,000 lawsuits brought by users of Zantac who claimed the heartburn drug caused their cancer. The agreement frees the British ...

ranitidine, turned into the potential carcinogen NDMA under certain conditions. The US Food and Drug Administration asked companies producing Zantac to remove all ranitidine-based drugs from the U ...

GSK PLC will pay up to $2.2 billion to settle some 80,000 US lawsuits over its heartburn medication Zantac, generically known ...